Key result
Among patients with hip fractures treated with dextran prophylaxis, the preoperative prevalence of thromboembolic disease was 9% and the postoperative incidence was 11%.
Cohort (n=176)
Hip fracture patients have a significant risk of preoperative and postoperative deep-venous thrombosis despite dextran prophylaxis, particularly in the injured extremity.
Answers are grounded in this paper and cite their sources.
High preoperative/postoperative DVT rates despite dextran in hip fracture patients warrant caution; this Level 3 data leaves open optimal prevention strategies.
A prospective preoperative and postoperative venographic study of hip fracture patients has documented a significant preoperative prevalence and postoperative incidence of thromboembolic disease. A statistically higher incidence of deep-venous thrombosis is observed in patients with femoral neck fractures compared to patients with intertrochanteric fractures. A 9% (15 of 176) preoperative prevalence and an 11% (12 of 108) incidence of new postoperative thromboembolic disease were detected. There was a predilection for deep-venous thrombosis in the injured extremity compared to the noninjured extremity both preop-eratively and postoperatively.
No takes yet. Share an insight, caveat, or question.
Roberts et al. (1990) conducted a cohort in Hip fractures (n=176). Hip fractures treated with dextran prophylaxis was evaluated on Preoperative prevalence and postoperative incidence of thromboembolic disease. Among patients with hip fractures treated with dextran prophylaxis, the preoperative prevalence of thromboembolic disease was 9% and the postoperative incidence was 11%.
Synapse has enriched 10 related papers. Consider them for comparative context: